RxDoctor Payments Data

Simon Chao, MD

Orthopaedic Surgery · North Easton, MANPI 1144481532

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (56.7%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 48 manufacturers reported payments, led by Republic Spine at 56.2% of the total. 2025 is the largest year on record at $501,435, 5.1 times the $97,682 reported in 2019. Among orthopaedic surgery clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,562,436in general payments, 2019–2025

Across 481 payments — averaging $3248.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Republic Spine$878K
  • Osseus Fusion Systems, LLC$287K
  • Life Spine, Inc.$83K
  • Surgentec$72K
  • Captiva Spine Inc$53K
  • Spinal Elements, Inc.$30K
  • plus $159K from 42 others
$25,000in research payments, 2019–2025

Across 1 payment — averaging $25,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanara Medtech Inc.$25K
$264in ownership & investment interests, 2019–2025

Across 7 payments — averaging $37.73 each. An ownership or investment interest held by the physician or an immediate family member.

  • Spineology Inc.$264

What the payments were for

  • Royalty or licence$885,27957%
  • Consulting fees$607,28539%
  • Speaking & faculty fees$20,8891%
  • Travel & lodging$17,0191%
  • Food & beverage$28,5892%
  • Education$3,3750%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,562,436 in reported general payments places this provider in the 95th percentile of 542 orthopaedic surgery providers in Massachusetts.

See all orthopaedic surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$659,866
Medicare patients
911
Services billed
5,101

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone240$1,864
Gabapentin37$414
Duloxetine Hcl15$267
Cyclobenzaprine Hcl18$210
Mupirocin14$82

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in North Easton

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →